USU: Younger Colon Cancer Patients Appear Overtreated

by U.S. Medicine

June 14, 2017

BETHESDA, MD — While young and middle-aged patients are much more likely to receive postoperative chemotherapy than older patients, they don’t appear to survive any longer from colon cancer, a new study reported.

A JAMA Surgery article recently noted that incidence and mortality rates among adults age 50 and older have decreased recently in the United States—but not for patients ages 20 to 49. Furthermore, according to study authors from the Uniformed Services University of the Health Sciences (USU), treatment options aren’t always clear for patients with young-onset colon cancer, nor are the effects on prognosis well-quantified.1

For the study, researchers examined whether there were age differences in receiving chemotherapy and whether there were matched survival gains with the receipt of postoperative chemotherapy among colon cancer patients. To do that, they analyzed data from the DoD’s Central Cancer Registry and MHS medical claims databases, focusing on 3,143 patients, 59% male, ages 18 to 75, and with histologically confirmed primary colon cancer diagnosed between 1998 and 2007.

Results indicated that young (18-49 years) and middle-aged (50-64 years) patients were two to eight times more likely to receive postoperative systemic chemotherapy, compared with older patients (65-75 years), regardless of tumor stage at diagnosis.

In addition, young and middle-aged adults were 2.5 times more likely to receive multi-agent chemotherapy regimens. Undergoing surgery alone improved survivability for young and middle-aged adults compared to older patients, but the researchers found no significant differences in survival between young/middle-aged and older patients who also received postoperative systemic chemotherapy.

“Most of the young patients received post-operative systemic chemotherapy, including multi-agent regimens, not currently recommended for most patients with early-stage colon cancer,” said lead researcher Kangmin Zhu, MD PhD, professor in USU’s Department of Preventive Medicine and Biostatistics, “Our findings suggest young and middle-aged adults with colon cancer may be over-treated.”

  1. Manjelievskaia J, Brown D, McGlynn KA, Anderson W, Shriver CD, Zhu K. Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Colon Cancer. JAMA Surg. 2017 Jan 25. doi: 10.1001/jamasurg.2016.5050. [Epub ahead of print] PubMed PMID: 28122072.

Comments are closed here.


Related Articles

What Will Be Cost of VA’s Legacy EHR System During Changeover?

GAO Suggests VistA Will Be Around for Next Decade WASHINGTON—As VA moves forward with the comprehensive overhaul of its electronic health records system, the department will still need to keep its legacy EHR system functioning... View Article

Five Miles High? VA Document Backlog Is Stacking Up, OIG Reports

WASHINGTON—If stacked, VA’s backlog of paper medical documents that are waiting to be digitalized—most generated by veterans’ visits to non-VA providers—would be over 5 miles high, according to a report from the VA inspector general.... View Article


U.S. Medicine Recommends


More From department of veterans affairs

Department of Veterans Affairs (VA)

What Will Be Cost of VA’s Legacy EHR System During Changeover?

GAO Suggests VistA Will Be Around for Next Decade WASHINGTON—As VA moves forward with the comprehensive overhaul of its electronic health records system, the department will still need to keep its legacy EHR system functioning... View Article

Department of Veterans Affairs (VA)

Five Miles High? VA Document Backlog Is Stacking Up, OIG Reports

WASHINGTON—If stacked, VA’s backlog of paper medical documents that are waiting to be digitalized—most generated by veterans’ visits to non-VA providers—would be over 5 miles high, according to a report from the VA inspector general.... View Article

Department of Veterans Affairs (VA)

Year Supply of Contraceptives Prevents More Unintended Pregnancies

Birth Control Pill Change Could Save VA $2 Million Annually PITTSBURGH—What if there was a method to prevent nearly 600 unintended pregnancies and save the VA about $2 million a year in prenatal, birth and... View Article

Department of Veterans Affairs (VA)

VA Says It Is Working to Resolve Whistleblower Retaliation Issues

WASHINGTON—According to VA officials, the agency is well on its way to creating a culture that will allow whistleblowers to feel safe to report facility problems without fear of retaliation from supervisors. Yet, whistleblower advocates... View Article

Department of Veterans Affairs (VA)

Genetic Mutations Affecting Response to Drugs Are Common in Veterans

VA Debates Who Should Receive Pharmacogenetic Testing SALT LAKE CITY—A massive VA study revealed that 99% of veterans have at least one genetic mutation known to affect response to specific drugs, including some commonly prescribed... View Article

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up